Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.
Well-regarded IP boutique with strong offerings in the Netherlands, Spain and Belgium. Particularly respected for its patent litigation on behalf of leading pharmaceutical and biotechnology companies. Additionally offers regulatory strength, assisting clients with questions relating to market exclusivity, parallel import and regulatory data protection. Further strength in enforcement of rights and cases relating to biosimilars.
A source praises the firm's "international reach, European experience and responsiveness."
"They work really well with their own network of offices in Europe; everything is supervised from their headquarters," enthuses a client, who adds: "They prepare themselves really accurately and co-ordinate themselves outstandingly with their international network. They have good bench depth."
Key contacts in the firm's life sciences group are Carla Schoonderbeek, based in Amsterdam, Liesbeth Weynants in Brussels, Luis Fernández-Novoa in Madrid and Benoît Strowel, who divides his time between Paris and Brussels.
This content is provided by HOYNG ROKH MONEGIER.
HOYNG ROKH MONEGIER has a long history of working with innovative pharmaceutical companies to protect and maximize their intellectual property rights and assets. Our top-tier litigators help many of the world's largest pharmaceutical companies achieve their goals by advising on and litigating issues relating to patent and SPC infringement and validity, regulatory data protection, theft of trade secrets, antitrust violations, trade marks and advertising.
We also act for innovative clients of all sizes, from global leaders to small start-ups, in the medical devices and diagnostics sector.
Our Life Sciences Regulatory practice covers all aspects of the development of medicinal products and medical devices. We advise on clinical trials (GCP), market authorisations, regulatory exclusivity, manufacturing (GMP), supply chain management, pharmaco- and materiovigilance, distribution, marketing and promotion, compliance, relationships with healthcare professionals, market access (in particular pricing and reimbursement strategies), patient support programmes, parallel trade, tenders, and privacy and data protection.
We advise and represent clients in their dealings with EU and national regulatory authorities and, if necessary, before the EU and national courts. For many years, we have represented the headquarters and local entities of a number of global pharmaceutical and biotech companies in EU and cross-border litigation and coordinated their legal representation across the EU.
Köhler, Martin (Head of Department)
Hessel, Tobias J.
Schmitz, Thomas H.
Aerospace, automotive & marine
Biotechnology & Biologics
Electronics, computers, software & semiconductors
Fashion & Luxury goods
Industrial equipment & Manufacturing
Retail & Consumer goods
Telecommunications & Networks